investingisatrickygame
10 Jan 2019
February 7th Proactive Investors Presentation Proactiveinvestors UK Proactive Investors One2One Investor Forum - London Thursday the 7th February 2019,Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair
investingisatrickygame
05 Jun 2018
New Technologies - Eden/Bayer/Syngenta Panel [link] Bayer and Syngenta.VERY interesting and Sean Smith contributes very well.
Deckhard
02 May 2018
Re: EU Pesticide Ban Announced Today With all the publicity recently in investment papers and now the EU ban on some chemical pesticides, are Eden braking out of the 8-13p trading range of the past 18 months? Fingers crossed.
investingisatrickygame
27 Apr 2018
EU Pesticide Ban Announced Today [link] assume this to be a good opportunity for Eden and their professional help to capitalise on this announcement and further vocalise the developments of a British company in delivering natural solutions to compete against traditional pesticides, herbicides and insecticides.Furthermore, this is probably, hopefully, just an initial step by the EU on a larger scale attack against harmful chemical products that would naturally lead companies to either/and 1)escalate their R and D 2) Seek out alliances with companies who are further advanced in non-chemical deliverables 3) buy companies that offer 2)Great News for Eden
investingisatrickygame
03 Apr 2018
Eden in Shares Magazine From last ThursdayHere is the full article below from Shares Magazine Eden Research to yield a rich harvest Cultivate a position in the agrochemicals play Under-the-radar Eden Research (EDEN:AIM), whose backers include Livingbridge UK Micro Cap Fund (GB00BV9FVS80) and Artemis Alpha Trust (ATS), looks an attractive proposition.A provider of breakthrough 'natural microencapsulation technologies' and agrochemicals, the AIM company is shifting from a development to a lucrative commercialisation phase, with strong growth set to continue in 2018 driven by new regulatory approvals.ENCAPSULATING EDENEden provides sustainable solutions for crop protection, animal health and personal care. Significant investment in intellectual property and registrations has created a competitive advantage in a global agrochemicals industry increasingly shifting towards biological products.The Cirencester-based concern's encapsulation technology, known as Sustaine and currently licensed to Bayer Animal Health in North America, is used in markets such as crop protection, animal and human healthcare . Like humans and animals, plants have developed defences against pests and disease. Among their defences are essential oils containing active molecules (terpenes), which help them combat insect predators and disease.Sustaine encapsulates these active molecules in particles that slow their release over days.This not only ensures better levels of control, but also improves the effectiveness of existing products used for plant protection such as pesticides and biocides. MAKING GRAPE PROGRESS Excitingly, the AIM minnow's first fungicide product Mevalone, which targets Botrytis (grape rot), is approved for sale in 10 nations including the top three wine producers {Italy, France, Spain). Further approvals are expected in 2018 with applications for registration being progressed in countries including the US and Australia.Eden has a second plant protection product, a nematicide named Cedroz, which targets soil-dwelling pests. This is on course for launch in 2019 and CEO Sean Smith says it has potentially a far greater market opportunity than Mevalone. Last summer Sipcam, an Italian multinational that specialises in making and marketing agrochemicals, invested £2.2m for a 9.9% stake in Eden. The pair have inked a numberof commercial agreements, giving Eden's agrochemicals and technologies credibility, while an eventual bid from the family -owned Sipcam is far from out of the question.POSITIVE BREAKTHROUGH NEARSEden's full year results {20 Mar) revealed a revenue leap to £1.9m (2016: £0.4m), despite a testing southern European growing season for its fungicidal products, flowing through to a significantly lower underlying pre-tax loss of£1.lm (2016: £1.9m); Eden also closed the year with £3.7m of cash in the bank. For 2018, Shore Capital's Phil Carroll forecasts a sales surge to £3.l m, ahead of £4m and £5.7m in 2019 and 2020 respectively, while the analyst's projections point to a breakthrough into positive EBITDA of £100,000 in 2019. SHARES SAYS: 1' Patient micro cap punters should pocket Eden at 8.25p for exciting growth prospects. (JC) BROKER SAYS: n /a 50 I SHARES I 29 March 2018
investingisatrickygame
03 Apr 2018
Eden in The Daily Mail Very good article and a follow up piece from Proactive[link]
investingisatrickygame
24 Mar 2018
Two Film Interviews This Week 1) Eden were on a station called London Live last Monday. London Live is a local TV station owned by The Evening Standard. Tune in at 7 mintes 50 seconds to see how they are saving grape farming (table and wine) from disease. They mention Champagne and Chablis in this short film[link] 2) A Proactive Investors interview from this week [link]
feoffor
22 Mar 2018
Ecological disaster in France [link] French countryside is becoming a veritable desert" because of the catastrophic decline in insects and the resulting reduction in bird population.The wipeout is put down to extensive use of pesticides.Is this a selling opportunity for EDEN?
ash6666
11 Jan 2018
Year-end trading update Eden Research plc (AIM: EDEN), the AIM listed company that develops and supplies breakthrough biopesticide products and natural microencapsulation technologies to the global agrochemicals, animal health and consumer products industries, provides the following trading update for the year ended 31 December 2017. The Group has delivered a robust performance for the year with revenue expected to be in the region of £1.9m, significantly up from £0.4m in 2016, with a loss before tax of approximately £0.9m (2016: loss of £1.9m). Cash at bank at 31 December 2017 was c. £3.7m (2016: £1.5m). This was a good performance since the 2017 growing season was challenging for fungicidal products in many southern European countries due to hard frosts in April followed by high heat and drought in the summer. These well-documented conditions resulted in the smallest harvests in 60 years in key markets such as France and Italy. During the year, regulatory approval was granted for Eden's first agrochemical fungicide product, 3AEY, and first commercial sales were achieved in France with further approvals received in Cyprus, Albania and Portugal. The Company extended its 3AEY patent protection in Spain, Greece, Bulgaria and Cyprus and its nematicide patent was granted in the US. Overall, the Company is encouraged by the level of sales of 3AEY and its continued acceptance into the market. Eden's patent portfolio grew to 78 granted patents during the year (2016: 74) with a further 52 pending patents (2016: 38). Multiple commercial agreements were signed with Sipcam SpA ("Sipcam"
during the year, including an Evaluation and Option Agreement, for which a fee of €0.6m (£0.5m) was paid to Eden, and a Collaboration Agreement establishing a long-term collaborative partnership. As reported on 12 December 2016, Eden's distribution partner, Eastman Chemical, announced the submission of the regulatory dossiers for its new nematicide, CedrozTM, which was developed by Eden. Cedroz will be a new tool for farmers to control a wide range of economically important nematodes with the first sales expected in advance of the 2020 growing season. Eastman made significant progress during the year with the submission of applications for the far-reaching registration of Cedroz across a number of territories and are building an impressive platform for the commercialisation of Cedroz as an important solution to the challenges that nematodes create for farmers globally. Sean Smith, Chief Executive Officer of Eden, said: "2017 was a good year for the Company with a number of significant advancements made. We remain focussed on execution under our recent agreements with Sipcam and Eastman Chemical, as these partnerships provide us with resources and capabilities to achieve strong future growth. For the first time since launching 3AEY in 2015, Eden will benefit from a full season of sales in 2018 in the world's top three wine producing countries of Italy, France and Spain. Additionally, sales will continue to develop in Albania, Bulgaria, Cyprus, Greece, Kenya and Portugal. "Despite challenging growing conditions in key territories and a shortened marketing campaign in France, we are pleased with the progress made in 2017 and we look forward to providing a further update when we report our full year results for the year ended 31 December 2017 in March."
investingisatrickygame
18 Sep 2017
Global Bio-Pesticide to show CAGR of 15% Courtesy of supersonico on advfn[link]
investingisatrickygame
17 Sep 2017
"I Think It's The Future For Agriculture" Courtesy of 33mick on advfn[link] think it’s the future for agriculture in the world.”"It’s hoped Mevalone, which has just been approved for use in France and several other European countries, could help France recover its world position as the world’s biggest wine producer.""Some believe Mevalone could revolutionize grape-growing around the world."
ash6666
01 Sep 2017
Notice of Interim Results Eden Research plc (AIM: EDEN), the AIM listed company that provides breakthrough natural microencapsulation technologies to the global agrochemicals, animal health and consumer products industries, will report its interim results for the six months ended 30 June 2017 on 29 September 2017.
ash6666
19 Aug 2017
Re: Up 6% on small volume Surely we must be getting sales news soon. The SP will go nowhere without it.
Deckhard
18 Aug 2017
Up 6% on small volume Any news??
investingisatrickygame
19 Jul 2017
Strawberry Market Today's paper [link] Strawberry Market [link] strawberries was the first picture on the inside of the 2016 accounts. I cannot remember the commentary.A recent Sipcam press article said they would be looking to the US and China in their relationship with Eden. Could this mean strawberries too?!
